- Home
- ZENA vs SGMO Comparison
ZENA vs SGMO Comparison
Compare ZENA & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENA
- SGMO
- Stock Information
- Founded
- ZENA 2017
- SGMO 1995
- Country
- ZENA Canada
- SGMO United States
- Employees
- ZENA N/A
- SGMO N/A
- Industry
- ZENA
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZENA
- SGMO Health Care
- Exchange
- ZENA NYSE
- SGMO Nasdaq
- Market Cap
- ZENA 109.4M
- SGMO 122.8M
- IPO Year
- ZENA N/A
- SGMO 2000
- Fundamental
- Price
- ZENA $3.36
- SGMO $0.54
- Analyst Decision
- ZENA Strong Buy
- SGMO Buy
- Analyst Count
- ZENA 1
- SGMO 6
- Target Price
- ZENA $9.00
- SGMO $4.50
- AVG Volume (30 Days)
- ZENA 10.0M
- SGMO 5.9M
- Earning Date
- ZENA 01-01-0001
- SGMO 08-05-2025
- Dividend Yield
- ZENA N/A
- SGMO N/A
- EPS Growth
- ZENA N/A
- SGMO N/A
- EPS
- ZENA N/A
- SGMO N/A
- Revenue
- ZENA $1,744,794.00
- SGMO $63,756,000.00
- Revenue This Year
- ZENA N/A
- SGMO N/A
- Revenue Next Year
- ZENA N/A
- SGMO N/A
- P/E Ratio
- ZENA N/A
- SGMO N/A
- Revenue Growth
- ZENA 24.50
- SGMO 239.92
- 52 Week Low
- ZENA $1.41
- SGMO $0.30
- 52 Week High
- ZENA $12.43
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- ZENA N/A
- SGMO 52.47
- Support Level
- ZENA N/A
- SGMO $0.51
- Resistance Level
- ZENA N/A
- SGMO $0.61
- Average True Range (ATR)
- ZENA 0.00
- SGMO 0.04
- MACD
- ZENA 0.00
- SGMO 0.01
- Stochastic Oscillator
- ZENA 0.00
- SGMO 65.90
About ZENA ZENATECH INC
ZenaTech Inc is a enterprise software technology company that specializes in mission-critical cloud-based applications integrated with smart hardware to deliver solutions across diverse industries. The company operates in software development technology, sales, and distribution. The company is also developing a drone manufacturing, sales, and distribution business. It generates revenue from software licensing and subscription agreements, software support and maintenance, and technology consulting services.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.